DIN 02562383 — LEQEMBI 100 MG
LEQEMBI is a solution of Lecanemab marketed by EISAI LIMITED. The full Lecanemab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02562383
- Brand name
- LEQEMBI
- Active ingredient
- Lecanemab
- Strength
- 100 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- EISAI LIMITED
- Health Canada status
- MARKETED
- Drug class
- Anti-amyloid beta monoclonal antibody
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.